U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06860750) titled 'A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis' on March 02.

Brief Summary: The study is being conducted to evaluate the efficacy and safety of SHR-1314 injection in adult patients with active non-radiographic axial spondyloarthritis.

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Active Non-radiographic Axial Spondyloarthritis

Intervention: DRUG: SHR-1314 Injection

SHR-1314 injection.

DRUG: SHR-1314 Placebo Injection

SHR-1314 placebo injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Published ...